Completed PHASE4 INTERVENTIONAL 2-arm NCT03451019

Different Effects of Non-calcium Phosphate Binders on Serum Calcium

Effect of Lanthanum Carbonate and Sevelamer Hydrochloride on Gastrointestinal Calcium Absorption in Patients With Moderate to Advanced Chronic Kidney Disease

Sponsor: Medical University of Lodz

Conditions Chronic Kidney Disease

Interventions Lanthanum Carbonate Sevelamer Hydrochloride

Updated 7 times since 2018 Last updated: Jul 26, 2021 Started: Mar 1, 2018 Primary completion: Dec 15, 2020 Completion: Dec 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03451019, this PHASE4 trial focuses on Chronic Kidney Disease and remains completed. Sponsored by Medical University of Lodz, it has been updated 7 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Sep 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Sep 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Mar 2018 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of Lodz
Shire

Data source: Medical University of Lodz

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lodz, Poland